Send PM
Followers 28
Posts 1014
Boards Moderated 0
Alias Born 03/10/2014

Re: None

Wednesday, 09/08/2021 8:46:02 AM

Wednesday, September 08, 2021 8:46:02 AM

Post# of 4237
SANOFI has bought two small US Biopharmas in the past two months...and they are looking to get into the COVID-19 race as well...
Hmmmmmm.....could ADAMIS be a target too?


France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal

PARIS, Sept 8 (Reuters) - French drugmaker Sanofi said on Wednesday it would buy U.S. biopharmaceutical company Kadmon Holdings for 1.9 billion dollars, one month after announcing the purchase of another US biotech, Translate Bio, for $3.2 billion.

Sanofi said it has offered $9.50 per share in cash for Kadmon, representing a total equity value of approximately $1.9 billion on a fully diluted basis, and that both companies' boards unanimously approved the transaction.

Sanofi's price tag represents a 79% premium on Kadmon's $5.30 closing price on Tuesday.

"The acquisition supports Sanofi's strategy to continue to grow its general medicines core assets and will immediately add Rezurock (belumosudil) to its transplant portfolio," the two companies said in a joint statement.

Rezurock, a treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD), was approved in July by the U.S. Federal Drug Administration (FDA).

"Kadmon's pipeline includes drug candidates for immune and fibrotic diseases as well as immuno-oncology therapies", the companies said.

Sanofi is under pressure to revive its drug pipeline and is also eager to overcome setbacks in the COVID-19 vaccine race.


In My Own Personal Opinion Of Course!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Recent ADMP News

FEATURED Worldwide Crypto Based Exchange Traded Products AUM Dropped 17% in November Dec 7, 2022 8:55 AM

Branded Legacy, Inc. Adds Subsidiary Bringing Additional $750,000 in Revenues BLEG Dec 7, 2022 8:00 AM

BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem Targeting Polycystic Ovary Syndrome as an Indication BRTX Dec 6, 2022 9:52 AM

Maison Luxe Announces Additional $250,000 Purchase Order from Signet International Group for Upcoming Holiday Season MASN Dec 6, 2022 8:10 AM

$10.97 Billion Potential Global Condom Market Could be a Key Driver of Growth for Israeli Cannabis Technology Company BYND Cannasoft Enterprises BYND Dec 5, 2022 8:00 AM

Electromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022 EMED Dec 5, 2022 7:15 AM

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Files EZ-G Patent Application to Include Double Faceted Condom BYND Dec 2, 2022 10:38 AM

Healixa Inc. Appoints Former Acting Secretary of Defense of The United States Christopher C. Miller to Its Advisory Board EMOR Dec 1, 2022 9:20 AM

Kona Gold Beverage, Inc's Gold Leaf Distribution Subsidiary Posts Record Revenue Month in November KGKG Dec 1, 2022 9:00 AM

Mullen Automotive Officially Closes on Acquisition of ELMS Assets, Takes Possession of Plant in Mishawaka, Ind., All Intellectual Property and Related Inventory MULN Dec 1, 2022 8:31 AM

HealthLynked Announces Points Reward Program for Online Medical Supplies Purchases HLYK Dec 1, 2022 8:00 AM

InnerScope Hearing Technologies (OTC: INND) Launches Its iHEAR Brand of OTC Hearing Aids on CVS.com INND Dec 1, 2022 8:00 AM

Aduro Announces Completion of Mechanical Assembly of its R2 Plastic Reactor ACT Dec 1, 2022 7:59 AM

Fission 3.0 Intersects Off-Scale Mineralization in the First Follow Up Hole at PLN A1 Discovery FUU Nov 30, 2022 8:21 AM

Healixa Expands Advisory Board with Appointment of Accomplished C-Level Executive with History of Accelerating Profitable Growth EMOR Nov 29, 2022 9:26 AM